Job Details

Executive Director, Analytics & Insights (NSCLC)

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Reporting directly to the Vice President, US Analytics & Insights, this role will serve as the analytics and insights leader dedicated to the Lung franchise, supporting launch planning and commercialization readiness for lung cancer assets. This individual will play a critical role in shaping franchise strategy through data-driven insights, while closely collaborating with forecasting, commercial, medical, and market access partners.

This leader will operate as a player/coach, balancing hands-on analytical leadership with team development, and will be expected to personally contribute to high-priority strategic analyses while building and scaling a high-performing team.

Candidates should bring deep oncology expertise, strong leadership capabilities, and a track record of translating complex data into actionable business insights within a fast-growing organization. This position is based out of our headquarters in Redwood City, CA.

Responsibilities include:

• Serve as the franchise lead for Analytics & Insights for Lung, ensuring readiness to support successful launch planning, commercialization, and performance tracking in the US market.
• Lead generation of strategic insights from market research and advanced analytics to inform critical business decisions and franchise strategy.
• Operate as a player/coach, directly conducting and guiding critical analyses while mentoring team members and establishing best practices across the function.
• Partner closely with forecasting, finance, and portfolio strategy teams to provide key inputs, assumptions, and insights that inform forecast development (note: this role does not own forecasting).
• Collaborate with global insights & analytics, commercial, medical affairs, and market access teams to define business questions, shape research objectives, and understand evolving market dynamics in lung cancer.
• Translate complex datasets into clear, compelling insights and recommendations, and effectively communicate to senior leadership and cross-functional stakeholders.
• Oversee the design and execution of primary and secondary market research, including vendor selection and management, ensuring application of best practices and fit-for-purpose methodologies.
• Partner with Marketing, Sales, Market Access, and Information Systems to:
• Define key performance indicators (KPIs)
• Oversee the development of dashboards and reporting infrastructure
• Enable data-driven performance monitoring and decision-making
• Serve as a strategic thought partner to franchise leadership, identifying key business drivers, risks, and opportunities.
• Drive adoption of innovative analytics approaches, including artificial intelligence, advanced analytics, competitive intelligence, and emerging data sources.
• Build, lead, and develop a high-performing team supporting the Lung franchise.

Required Skills, Experience and Education:

• Advanced degree (PhD, PharmD, MD, MBA, or equivalent) in a scientific or business discipline.
• 12+ years of relevant experience in biotech, pharmaceutical, or consulting environments, consistent with Executive Director-level expectations at RevMed.
• Deep experience in oncology, with strong preference for lung cancer expertise.
• Demonstrated success supporting product launches and commercialization in oncology.
• Strong leadership experience, including building and leading high-performing teams, with a demonstrated ability to operate effectively as a hands-on player/coach.
• Expertise in market research, data analytics, and strategic insight generation; ability to translate data into strategy.
• Experience working in close partnership with forecasting and finance teams, providing analytical inputs without direct ownership of forecasting.
• Excellent communication skills with the ability to influence senior leadership and cross-functional stakeholders.
• Strong business acumen and ability to operate effectively in a fast-paced, evolving environment.

Base Pay Salary Range

$265,000 - $331,000 USD